Full-Time

Director – Product Management

Confirmed live in the last 24 hours

Click Therapeutics

Click Therapeutics

51-200 employees

Develops software as prescription medical treatments

Compensation Overview

$220k - $250k/yr

+ Annual Performance-Based Cash Bonus + Equity Package

Senior, Expert

New York, NY, USA

Hybrid working model requiring at least 3 days in office each week.

Category
Product Management
Product
Required Skills
Agile
Product Management
Requirements
  • 10+ years of experience working in a product role in an agile environment for mobile products.
  • 4+ years of experience leading product management teams.
  • Experience developing strong relationships with external partners and stakeholders.
  • High ownership and agency with a strong bias for action to create the change you wish to see.
  • Excellent verbal and written communication skills work with peers, stakeholders, and upper management.
  • Strong technical leadership, project management, analytical problem solving, business analysis, and troubleshooting skills.
  • Experience translating technical concepts and solutions to non-technical and executive audiences.
  • Passionate about improving healthcare, have experience in the space or a personal connection.
  • You are excited and inspired by the practice of building exceptional, high performing teams.
Responsibilities
  • You’ll manage Product Managers and teams across the Click product portfolio establishing the processes, practices, and culture to empower teams to build effective, efficacious, and delightful products.
  • You will work with Product Managers to drive product vision, strategy, and long term roadmaps for our portfolio products.
  • You will coach, manage, and mentor high performing product managers on the skills to help them further develop and achieve their long term career goals.
  • You will build and manage relationships with our collaborative pharmaceutical partners that enables our products and collaborations to be successful.
  • You will focus on building a culture that elevates the team’s performance and morale and makes Click a leading place to practice product management.
  • You will establish processes which increase the team’s effectiveness.
  • You will deeply understand our patients and products, practicing and evangelizing patient-centric thinking in the definition of new digital therapeutics that improve the health of Click’s patients.
  • You will work within and across teams to drive effective teamwork, communication, collaboration and commitment across multiple departments.
  • You will advocate for and evangelize product management best practices.
Desired Qualifications
  • Background or previous experience in neuroscience, psychiatry, psychology, behavior change, digital health or a related field.
  • Understanding of the US healthcare ecosystem including reimbursement and regulatory dynamics.
  • Experience developing consumer facing products.

Click Therapeutics develops software applications that function as prescription medical treatments for patients with various health conditions. These digital therapeutics are designed to change cognitive and neurobehavioral mechanisms related to diseases, and they are tested through rigorous randomized controlled trials to ensure safety and effectiveness. After validation, the company seeks FDA clearance to market these applications as class II medical devices. Unlike traditional pharmaceuticals, Click Therapeutics' products are prescribed by physicians and reimbursed by payers, allowing for a unique revenue model. A notable collaboration with Boehringer Ingelheim aims to create a digital therapeutic for schizophrenia, highlighting the potential of this approach in healthcare. The company's goal is to provide effective digital solutions for patients with unmet medical needs.

Company Size

51-200

Company Stage

Debt Financing

Total Funding

$161.6M

Headquarters

New York City, New York

Founded

2012

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA clearance of Rejoyn™ boosts credibility in digital therapeutics for depression.
  • Acquisition of Better Therapeutics expands Click's portfolio into cardiometabolic diseases.
  • Investment from Dassault Systèmes enhances Click's capabilities in digital therapeutics.

What critics are saying

  • Integration challenges with Better Therapeutics' assets may delay product rollouts.
  • Regulatory changes could impact approval timelines for digital therapeutics.
  • Dependence on partnerships like Boehringer Ingelheim poses commercialization risks.

What makes Click Therapeutics unique

  • Click Therapeutics specializes in software as medical treatments for unmet medical needs.
  • Their Clickometrics® platform personalizes user experience to optimize engagement and outcomes.
  • Partnership with Boehringer Ingelheim highlights their strong industry collaborations.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Company Match

Unlimited Paid Time Off

Flexible Work Arrangement

Stock Options

Performance Bonus

Fertility Treatment Support

Professional Development Budget

Commuter Benefits

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

5%

2 year growth

7%
Business Wire
Mar 20th, 2025
Dassault Systèmes Intensifies the MEDIDATA Commitment to Patient Experience With Investment in Click Therapeutics for Digital Therapeutics Beyond Clinical Trials

Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click Therapeutics, a leader in prescription digital therapeutics ...

The Healthcare Technology Report
Nov 28th, 2024
Click Therapeutics Launches Software-Enhanced Drug Therapies

Click Therapeutics launches Software-Enhanced Drug therapies.

Business Wire
Oct 8th, 2024
Click Therapeutics Founder and CEO David Benshoof Klein Named to 2024 PharmaVoice 100 List

NEW YORK-(BUSINESS WIRE)-David Benshoof Klein, founder and chief executive officer of Click Therapeutics, has been honored as a PharmaVoice 100 winner.

Business Wire
Aug 13th, 2024
Otsuka Precision Health and Click Therapeutics Announce Launch of Rejoyn(TM), the First-And-Only Prescription Digital Therapeutic Cleared by the FDA for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms

PRINCETON, N.J. & NEW YORK-(BUSINESS WIRE)-Otsuka Precision Health, Inc. (OPH) and Click Therapeutics, Inc., (Click) announce today the commercial launch of Rejoyn(TM).

Hit Consultant
May 22nd, 2024
Click Therapeutics Acquires Better Therapeutics, Expands into Obesity and Cardiometabolic Disease

- Click Therapeutics, a leader in prescription digital therapeutics (DTx), announced today the acquisition of key assets from Better Therapeutics.